This document outlines an exclusive GP-led secondary deal for Project Klein, expected to close in June 2018. The deal involves a mid-market buyout strategy focusing on business services and healthcare services in Europe/UK. Key investment data includes an invested capital of €60-100m, a discount to NAV of over 5%, and a gross multiple of 1.1x. The portfolio consists of four companies, including a UK premium distributor and a network of UK medical and cosmetics clinics. Glendower Capital is leading the transaction with a focus on leveraging their track record in complex transactions and performing extensive diligence.
doj/DataSet10/EFTA01394382.pdf
{"title":"SOF IV — Project Klein","key_people":["Glendower Team"],"document_date":"2018","document_type":"tabular","key_locations":["Europe","UK"],"document_subtype":"investment summary","key_organizations":["Glendower Capital"]}